Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $32.5000 (-1.08%) ($32.5000 - $32.5000) on Wed. May. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.38% (three month average) | RSI | 39 | Latest Price | $32.5000(-1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(41%) IWM(37%) IWO(37%) IWN(35%) SDY(34%) | Factors Impacting HALO price | HALO will decline at least -1.69% in a week (0% probabilities). UUP(-11%) TBT(-11%) IGOV(-11%) BNDX(-10%) IPO(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.69% (StdDev 3.38%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $32.94 | 5 Day Moving Average | $33.06(-1.69%) | 10 Day Moving Average | $33.48(-2.93%) | 20 Day Moving Average | $32.94(-1.34%) | To recent high | -29.8% | To recent low | 7.8% | Market Cap | $4.442b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |